Skip to main content

Site notifications

AusPAR Polivy

Australian Public Assessment Report
Device/Product Name
Polivy
Active ingredients
Polatuzumab vedotin
AusPAR Date
Published
Submission Number
PM-2021-05903-1-6
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site